Following U.S. Food and Drug Administration’s (FDA) EUA approval on May 10, the Centers for Disease Control (CDC) adopted CDC’s Advisory Committee on Immunization Practices’ (ACIP) recommendation that endorsed the safety and effectiveness of the Pfizer-BioNTech COVID-19 vaccine and its use in 12- through 15-year-old adolescents.